PMI-001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePMI-001
Drug Alias NamePMI-001
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionInterleukin-2 inhibitorsNitric oxide synthase, inducible inhibitorsCyclooxygenase-2 inhibitors +[4] 
TargetsCyclooxygenase-2Tumor necrosis factor αNitric oxide synthase, inducible +[4] 
Therapy Area/IndicationsPsoriasisMultiple SclerosisArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPhytomedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhytomedics IncNational Institute Of Arthritis And Musculoskeletal And Skin Diseases
Active IndicationsN/A
Inactive IndicationsPsoriasisMultiple SclerosisArthritis, Rheumatoid +[4] 

Other Information

ATC CodeN/A
Related LinksDrugBank